Summary
Chinese stocks remained largely range-bound on Monday, as gains in technology shares were offset by losses in the banking and insurance sectors. This occurred despite Beijing's announcement of a $54 billion capital-injection plan, with investors also monitoring China-US relations and US rate expectations.